Moreover, treatment of cells with the proteasome inhibitor MG132 led to accumulation of ubiquitinated MYC protein in ANXA2Y23A- but not ANXA2Y23D-overexpressing ESCC cells (Fig. 5e). This evidence concerns the gene MYC and esophageal squamous cell carcinoma.